Triple GIP/GLP-1/Glucagon Receptor Agonist8 mgInvestigational

8 mg Retatrutide Dosage Calculator

Convert your 8 mg retatrutide dose to the exact number of units for your vial concentration.

Retatrutide is an investigational medication currently in clinical trials. It has not been approved by the FDA for any indication.

050100

How many units is 8 mg of Retatrutide at 2 mg/mL?

Draw

400units

4.00 mL on a U-100 insulin syringe

8 mg ÷ 2 mg/mL × 100 = 400 units

This dose exceeds 50 units (0.5 mL). Volumes greater than 0.5 mL may be uncomfortable for subcutaneous injection. Consult your provider about splitting the dose into two injections.

For educational purposes only. Always follow your provider's instructions.

Quick Reference Table

All dose × concentration combinations

Dose2 mg/mL5 mg/mL10 mg/mL
1 mg502010
2 mg100*4020
4 mg200*80*40
8 mg400*160*80*
12 mg600*240*120*

Values in U-100 insulin syringe units

* Exceeds 50 units (0.5 mL) — may require splitting into two injections

There's an easier way

Tired of calculating doses?

We handle everything — the prescription, the right dose, and shipping straight to your door. No math, no hassle.

Get Started

2-min quiz · Free consultation · No commitment

About the 8 mg Dose

The 8 mg dose is a high-dose escalation step in the retatrutide clinical trial protocol, used during weeks 13 through 16. This dose represents a significant step up from 4 mg and moves patients into the upper therapeutic range. The triple-agonist mechanism at this level produces robust appetite suppression and enhanced metabolic activity across all three receptor pathways.

Frequently Asked Questions

In a 10 mg/mL vial, 8 mg retatrutide equals 80 units. The math is (8 / 10) x 100 = 80 units. In a 5 mg/mL vial, it would be 160 units, and in a 2 mg/mL vial, it would be 400 units — which would exceed a standard 100-unit syringe, so a higher concentration is recommended.

The 8 mg dose is the fourth step in the retatrutide clinical trial schedule, used during weeks 13 through 16. Patients have already completed 12 weeks of escalation through 1 mg, 2 mg, and 4 mg doses. After 4 weeks at 8 mg, the final escalation to the 12 mg maximum dose occurs.

Phase 2 trial data indicated that gastrointestinal side effects increased at higher doses, including 8 mg. Nausea, diarrhea, and vomiting were the most commonly reported effects. However, the gradual titration from 1 mg over 12 weeks before reaching 8 mg helped reduce the severity. Most side effects were mild to moderate and transient.

A 10 mg/mL vial is a practical choice for 8 mg dosing, requiring 80 units which fits within a standard 100-unit insulin syringe. A 5 mg/mL vial would require 160 units, exceeding a standard syringe capacity. For the most comfortable injection volume, a higher concentration vial would be optimal if available.

Other Retatrutide Doses

1 mg Retatrutide2 mg Retatrutide4 mg Retatrutide12 mg Retatrutide

Related Pages

Retatrutide CalculatorRetatrutide Dosing

Ready to Get Started?

Take our 2-minute quiz to see if you qualify for GLP-1 treatment.

Start Quiz

Free consultation. No commitment.